Aclarion (ACON) announced its Nociscan product is now available in Santa Monica at Medical Imaging Center of Southern California, or MICSC.

BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company ...

Aclarion, Inc. (ACON) appears an attractive pick ... They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective ...

Wall Street Analysts Forecast Growth Several research analysts recently issued reports on ACON shares. Ascendiant Capital Markets reduced their price target on shares of Aclarion from $502.50 to ...

Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market Nasdaq compliant: fully meets bid price and shareholder ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

allowing an investor to gain exposure to the trends within that segment. According to data from Benzinga Pro, ACON has a 52-week high of $231.15 and a 52-week low of $2.43.